Structure and synthesis of atalaphylline and related alkaloids

The structure of atalaphylline, (1; 1,3,5-trihydroxy-4-(γ,γ-dimethylallyl)acridone an alkaloid of Atalantia monophylla, was confirmed by oxidative degradation and by total synthesis. The synthesis involved the preparation of 1,3,5-trihydroxy-9-acridone followed by direct prenylation to give atalaphylline and a monoprenylated product.     

Synthese von verzweigten zuckern durch 1,4-addition an pyranosid-enone

Methyl (or ethyl) 2,3,6-trideoxy-α-l-glycero-hex-2-enopyranosid-uloses (6 or 7) may react with lithiocopperorganyles under 1,4-addition and introduction of a C-branching at C-2 of the 4-ulose. Similarly, 2-ethoxycarbonyl-2-lithio-1,3-dithiolane (14) reacts under 1,4-addition with 7 to give in high yield 15, which contains a highly functionalized side-chain at C-2. In a series of steps, the branched 2-C-glycoloyl-4-ulose 20 was obtained. All the 1,4-additions proceeded strictly stereoselectively and provided only the product in which the side-chain introduced at C-2 is in the “trans-” position to the anomeric glycosidic group. The addition is controlled by the anomeric group.     

Some aspects of the isopropylidenation of d-glucitol under neutral conditions

Isopropylidenation of d-glucitol (1) under neutral conditions, by treatment with 2,2-dimethoxypropane in 1,2-dimethoxyethane, has been studied. An improved procedure for the isolation of 1,2:5,6-di-O-isopropylidene-d-glucitol, the main equilibrium product, by direct crystallisation or via the 3,4-dibenzoate is described. Some aspects of the reaction are discussed and compared with results obtained previously from the isopropylidenation of 1 in the presence of zinc chloride.     

Synthesis and in vivo evaluation of 11-substituted estradiol derivatives as anti-implantation agents

Synthesis of 11-substituted estradiol derivatives (12–17) has been carried out by the Grignard reaction with alkyl, allyl, and benzyl halides on 17β-hydroxy-3-methoxy-11-oxo-estra-1,3,5(10),8(9)-tetraene (10). The novel compounds (10 and 12–17) were evaluated for their preliminary post-coital contraceptive (anti-implantation) activity in Sprague–Dawley rats. The tested compounds were administered orally and showed significant anti-implantation activity. Compound 13 is the most potent compound in the series which showed 100% contraceptive efficacy at 1.25 mg kg⁻¹.     

Diverse amide analogs of sulindac for cancer treatment and prevention

Sulindac is a non-steroidal anti-inflammatory drug (NSAID) that has shown significant anticancer activity. Sulindac sulfide amide (1) possessing greatly reduced COX-related inhibition relative to sulindac displayed in vivo antitumor activity that was comparable to sulindac in a human colon tumor xenograft model. Inspired by these observations, a panel of diverse sulindac amide derivatives have been synthesized and their activity probed against three cancer cell lines (prostate, colon and breast). A neutral analog, compound 79 was identified with comparable potency relative to lead 1 and activity against a panel of lymphoblastic leukemia cell lines. Several new series also show good activity relative to the parent (1), including five analogs that also possess nanomolar inhibitory potencies against acute lymphoblastic leukemia cells. Several new analogs identified may serve as anticancer lead candidates for further development.     

Colorimetric and fluorometric assays for acetylcholinesterase and its inhibitors screening based on a fluorescein derivate

A fluorescein-based sensor was developed for the AChE activity assay and the inhibitor screening. The sensor provided the dual assay methods for the screening of AChE activity in the presence or absence of inhibitor. The colorimetric and fluorometric assays were based on the following processes: (1) owing to the hydrolysis of acetylthiocholine in the presence of AChE, the fluorescein-based probe can rapidly induce 1,4-addition of the hydrolysis product thiocholine to α,β-unsaturated ketone in the compound 1, resulting in strong fluorescence and absorption changes; (2) in the presence of the corresponding inhibitor, the fluorescence enhancement or the absorption change would be inhibited in that the formation of thiocholine was hindered.     

Interactions of platinum—1-methyluracil blue and its hydrolysis products with DNA

The preparation of Pt(NH₃)₂(MeU)₂·2H₂O, 1. [(NH₃)₂Pt(MeU)₂Pt(NH₃)₂](NO₃)₂, 2. Pt(NH₃)₂Cl(MeU), 3. and (in solution) [Pt(NH₃)₂(OH)(MeU)], 4. (MeU = 1-methyluracil monoanion) is reported. Levels of l-methyluracil and 1–4 in platinum-l-methyluracil blue (PtMeUB) have been assessed by high performance liquid chromatography (HPLC). This technique has also been used to show that in physiological saline or water, PtMeUB hydrolyzes to 3 or 4, respectively. Visible spectroscopy shows that the rate of hydrolysis of PtMeUB is much faster in fetal calf serum than in saline or water, with HPLC indicating that the product of hydrolysis in serum is 3. The precipitate obtained upon treatment of DNA solutions with PtMeUB has also been shown to hydrolyze to 3 or 4 when suspended in saline or water. Compounds 1–3 have been tested against the Ascites S-180J tumors, with 2 and 3 being active, while 4 has been shown to react readily with DNA. Possible mechanisms of antitumor action of PtMeUB that involve 3 and 4 are proposed.     

Synthesis,anti-inflammatory,analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives

Design, synthesis and pharmacological activities of a group of 1,3,5-trisubstituted pyrazolines were reported. The chemical structures of the synthesized compounds have been assigned on the basis of IR, MS, ¹H NMR, and ¹³C NMR spectral analyses. The synthesized 1,3,5-trisubstituted pyrazoline derivatives were evaluated in vivo for anti-inflammatory, analgesic activities and in vitro for COX-1/2 inhibition assay. Among the tested compounds, derivatives 4h, 6e, 7a, 7e, and 9 showed more potent anti-inflammatory and analgesic activities than the reference drug celecoxib. On the basis of their higher activities in the in vivo studies compared with celecoxib, the five compounds 4h, 6e, 7a, 7e and 9 were selected to test their inhibitory activities against ovine COX-1/2 using an in vitro cyclooxygenase inhibition assay. Docking study of compounds 7a, 7e and 9 into the COX-2 binding site revealed a similar binding mode to SC-558, a selective COX-2 inhibitor.     

Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers

Neuronal sodium channels blockers interfere with ion flux and have been used for managing neuropathic pain, epilepsy, and cerebral ischemic disorders. In the current study, four groups of 2,4-diamino-1,3,5-triazine derivatives were synthesized and investigated for their neuronal sodium channels binding activity. 5-Aryl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamines (4a–4j) were found to have the best neuronal sodium binding activity among the four groups of triazines evaluated. Derivatives 4a–4j blocked the sodium channels with IC₅₀ values ranged from 4.0 to 14.7 μM. The result from this study showed that analogues of 2,4-diamino-1,3,5-triazines could be used as leads for the discovery of neuronal sodium channels blockers for managing central nervous system related disorders.     

Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives

Pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives 1a–c were prepared from 4-(N-methyl-N-phenylamino)-2-methylsulfanylpyrazolo[1,5-a]-1,3,5-triazine 2. Their cytotoxic activity, inhibition of tubulin polymerization, and cell cycle effects were evaluated. Compounds 1a and 1c are potent tubulin inhibitors and displayed specific antiproliferative activity in colorectal cancer cell lines at micromolar concentrations.     

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzymes and additional receptors. When dosed orally, compound 26 is efficacious in suppressing glucagon induced plasma glucose excursion in rhesus monkey and transgenic murine pharmacodynamic models at 1 and 10 mpk, respectively.     

Fungal hydroxylation of (−)-santonin and its analogues

Santonin (1) was incubated with separate growing cultures of Aspergillus niger ATCC 9142, Mucor plumbeus ATCC 4740, Whetzelinia sclerotiorum ATCC 18687, Cunninghamella echinulata var. elegans ATCC 8688a and Phanerochaete chrysosporium ATCC 24725. Three novel metabolites were isolated: 11β,13-dihydroxysantonin (3), 6,7-dehydosantonin (5) and 3,6-dihydroxy-9-keto-9,10-seco-selina-1,3,5(10)-trien-12-oic acid-12,6-lactone (7). 11β-Hydroxysantonin (2), 14-hydroxysantonin (4) and 3,6,9-trihydroxy-9,10-seco-selina-1,3,5(10)-trien-12-oic acid-12,6-lactone (6) were also isolated. Hydroxylation at C-9 followed by a retro-aldol reaction was postulated to have produced 6 and 7. Through the synthesis and fermentation of the santonin analogues: tetrahydrosantonin (8) and α-desmotroposantonin (12), several new compounds were obtained; the most significant being 9-keto-desmotroposantonin (14), which was indicative of C-9 monohydroxylation.     

Synthesis,characterization and in vitro biological evaluation of some novel 1,3,5-triazine–Schiff base conjugates as potential antimycobacterial agents

A series of some novel 1,3,5-triazine–Schiff base conjugates (1–32) have been synthesized and evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv using Alamar Blue assay and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Compounds 4 (4-Methoxy-6-methyl-N-(3,4,5-trimethoxybenzylidene)-1,3,5-triazin-2-amine), 11 (4-Methoxy-6-methyl-N-(2-hydroxy-3-bromo-5-chloro-benzylidene)-1,3,5-triazin-2-amine) and 24 (4-Methoxy-6-methyl-N-(1-(2,5-dihydroxyphenyl)ethylidene)-1,3,5-triazin-2-amine) exhibited a significant activity at 3.125, 6.25 and 6.25 μg/mL, respectively, when compared with the antitubercular drugs such as ethambutol (3.125 μg/mL), pyrazinamide (6.25 μg/mL) and streptomycin (6.25 μg/mL) and it could be a potential starting point to develop new lead compounds in the fight against Mycobacterium tuberculosis H37Rv.     

Purification of 2,5-anhydro-d-hexitol bis(phosphates) and identification of a major 1,4,6-tris(phosphate) contaminant by 31P-, 13C-, and 1H-N.M.R. spectroscopy

The reaction of two equivalents of diphenylchlorophosphate in cold pyridine with 2,5-anhydrohexitols has been assumed to result in only 1,6-bis(diphenylphosphate) products. However, by thin-layer, silica gel dry-column, and DEAE-Sephadex A-25 column chromatography, the products of this reaction have been shown to contain three major components; monophosphates (32 or 30%, by weight), 1,6-bis(phosphates) (40 or 56%), and 1,4,6-tris(phosphates) (28 or 14%): the former percentages for the product from 2,5-anhydro-d-mannitol (1) and the latter for the product from 2,5-anhydro-d-glucitol (10). The identity of each bis- and tris-(phosphate) of 1 or 10 was established by ³¹P- and ¹³C-n.m.r. spectroscopy. Acetylated bis- and tris-(diphenylphosphates) of 1 were also examined by ¹H-n.m.r. The significance of these findings on the interpretation of studies of the anomeric specificity of enzymes and on the specificity of the reagent diphenylchlorophosphate are discussed. The formation of only a 1,4,6-tris(phosphate) of 10 suggests that the 1,6-bis(diphenylphosphate) of 10 may undergo formation of a 1,3-cyclic phosphate triester by transesterification with elimination of phenol. A method for the determination of the number of cyclohexylammonium groups crystallizing with a sugar phosphate is proposed that simplifies the elemental analysis of this type of salt.     

Coupling of cationic olefin complexes of platinum(II) with potential ambident nucleophiles

The reactivity of [PtCl(η²-CH₂CHR)(tmeda)]⁺ (R = H, 1a, or Me, 1b; tmeda = N,N,N′,N′-tetramethyl-1,2-diaminoethane) towards some ambident nucleophiles like anilines and phenolate anion has been tested. The reaction of 1a with N-methylaniline gives immediately N-addition to the coordinated ethene (3a), but, in the presence of an inorganic carbonate, a partial rearrangement, with the para carbon of the phenyl ring taking the place of nitrogen, is observed (4a and 5a). Reaction with a tertiary aromatic amine, such as N,N-dimethylaniline, leads exclusively to the C-coupled species. The phenolate anion acts initially as an oxygen donor, however the resulting species (6a), in contact with free phenol, rearranges to C-bonded species (7a). For free phenol/6a ratios ? 5 the rearranged product has an isomeric ortho/para ratio of ≈3. For lower free phenol/6a ratios (? 1) oligomeric complexes, in which two or three platinum ethanide moieties are bound to the same phenol ring, are also formed. In the case of 1b, the above described reactivity has to compete with the base-induced deprotonation of propene, leading to formation of the allyl-bridged platinum dimer [{PtCl(tmeda)}(μ-η¹:η³-CHCHCH₂){Pt(tmeda)}]⁺. The X-ray crystal structure of 1b has also been determined; the structural parameters are very similar to those previously reported for 1a. DFT calculations have shown a similar activation of the two complexes towards nucleophilic addition at the coordinated olefin, although in 1b the electrophilic character of the olefin is masked by the Brønsted acidity of the propene methyl protons.     

Thiol activation of a model O-aryl diazeniumdiolate prodrug in phospholipid vesicle media

Thiolysis of the model diazeniumdiolate prodrug, O²-(2,4-dinitrophenyl) 1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DNP-DEA/NO, 1), by glutathione (GSH), cysteine (CYSH) and 1-heptanethiol (heptylmercaptan, HM) has been examined in anionic (DOPG), neutral (DPPC, DOPE) and cationic (DOTAP) vesicle media and in glycine buffered aqueous solutions. DOTAP vesicles accelerate the bimolecular reaction with glutathione, cysteine and 1-heptanethiol by factors of 81, 8.2 and 4630, respectively, while reaction is inhibited 5- to 10-fold in the presence of neutral and anionic vesicles. The intrinsic nucleophilicity of the thiols has been compared through the second-order rate constants, 22.9, 5.24 and 43.1 M⁻¹ s⁻¹, for nucleophilic attack on 1 by GS⁻, CYS⁻ and M⁻, respectively, obtained in buffered aqueous media. Analysis of the catalysis by DOTAP vesicles, using pseudophase ion-exchange formalism, suggests that the rate increase is due to reactant concentration in the bilayer and interfacial region coupled with enhanced dissociation of the thiol at the vesicle surface. Some contribution from enhanced nucleophilic reactivity at the vesicle interface may also contribute to the greater catalysis by HM. Inhibition of the thiolysis reaction by phospholipid liposomes is attributed to repulsion of the thiolate anions by the negatively charged acyl phosphate of the lipid head group. DOPG = 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)], DPPC = 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, DOPE = 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOTAP = 1,2-dioleoyl-3-trimethylammonium-propane.     

Nickel(II) and copper(II) complexes of tetradentate unsymmetrical Schiff base ligands: First evidence of positional isomerism in such system

The 1:1 condensation of 2,4-pentanedione and 1,2-diaminopropane gives a mixture two positional isomers of tridentate mono-condensed product 7-amino-4-methyl-5-aza-3-octene-2-one (HAMAO) and 7-amino-4,6-dimethyl-5-aza-3-heptene-2-one (HADAH) that reacted readily with Ni(II) thiocyanate to yield exclusively a single product, [Ni(AMAO)NCS] (1) in which the methyl substituent of diamine is ‘remote’ from the imino nitrogen. The mixture of terdentate ligands has been used for further condensation with pyridine-2-carboxaldehyde or 2-acetylpyridine to obtain the unsymmetrical tetradentate Schiff base ligands. The tetradentate ligands formed by the condensation of it and pyridine-2-carboxaldehyde readily yielded complexes with Cu(II) and Ni(II) (2 and 3, respectively). Crystal structure analysis shows that in 2 the condensation site of the diamine with 2,4-pentanedione is the same as in 1 but that in 3 is different (the methyl group of the diamine is located in the vicinity of 2,4-pentanedione), i.e., the tetradentate ligand is in two different isomeric forms in complexes 2 and 3. Another tetradentate ligand, obtained by the condensation of the tridentate ligands and 2-acetylpyridine yielded a Ni(II) complex (4) where the methyl group is in the vicinity of 2,4-pentanedione as in 3. The isomerization in the Ni(II) complexes has been studied by NMR spectroscopy.     

The inhibitory activity of 2-acetamido-2-deoxy-D-gluconolactones and their isopropylidene derivatives on 2-acetamido-2-deoxy-beta-D-glucosidase

2-Acetamido-2-deoxy-D-glucono-1,4-lactone (1) and 2-acetamido-2-deoxy-D-gluconic acid (3) have been examined for inhibitory activity against 2-acetamido-2-deoxy-β-D-glucosidase from bull epididymis. Crystalline 1 and 3 were compared with the known, crystalline 2-acetamido-2-deoxy-D-glucono-1,5-lactone (2), and a correlation of the activities of these compounds with various factors is presented. The inhibition constant of the 1,5-lactone 2 is lower (0.45μM) than that (4.43μM) of the 1,4-lactone 1. The effect of time is the opposite; whereas the activity of solutions of 2 decreases with time, solutions of 1 show an increase in inhibitory power, but both reach an equilibrium after 5 h. The free acid 3 exhibits no inhibitory activity. 2-Acetamido-2-deoxy-5,6-O-isopropylidene-D-glucono- 1,4-lactone (4) and 2-acetamido-2-deoxy-4,6-O-isopropylidene-D-glucono-1,5-lactone (5), which are appropriately protected to prevent conversion into the other lactone isomer, were also tested; 4 has 1/1000th the activity of 5.     

Design,synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors

A series of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties were obtained by reacting 4-isocyanato-benzenesulfonamide (2) with 2-amino-4,6-dicholoro-1,3,5-triazine (4). The 4-(3-(4,6-dichloro-1,3,5-triazin-2-yl)ureido) benzenesulfonamide (5) was subsequently derivatized by reaction with various nucleophiles such as, morpholine, ammonia, methyl amine, dimethyl amine, and piperidine. The ureido benzenesulfonamides incorporating triazinyl moieties were investigated as inhibitors of four selected physiologically relevant human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms, namely, hCA I, II, IX, and XII which are involved in various diseases such as glaucoma, epilepsy, obesity and cancer. The membrane-bound tumor-associated isoform hCA IX was potently inhibited with these compounds with K_is in the range of 0.91–126.2 nM. Specifically, compound 7j showed great potency against hCA IX with sub-nanomolar K_i of 0.91 nM. Since hCA IX is a validated drug target for anticancer agents, these isoform-selective and potent inhibitors may be considered of interest for further medicinal/pharmacologic studies.     

Tl benzene multicarboxylic acid coordination polymers: Structural, thermal and fluorescence studies

[Tl₃(μ-1,2,3-btc)]_n (1,2,3-H₃btc = 1,2,3-benzenetricarboxylic acid) (1), [Tl₂(μ-1,3,5-Hbtc)(H₂O)]_n (1,3,5-H₃btc = 1,3,5-benzenetricarboxylic acid) (2) and [Tl₄(μ-1,2,4,5-btc)]_n (1,2,4,5-H₄btc = 1,2,4,5-benzenetetracarboxylic acid) (3), three new Tl^I coordination polymers have been synthesized, characterized by elemental analysis and IR spectroscopy and their structures determined by single-crystal X-ray diffraction. The thermal stability of compounds 1-3 were studied by thermal gravimetric (TG) and differential thermal analyses (DTA). The single-crystal X-ray analysis of compounds 1-3 shows that the compounds are structurally diverse showing three-dimensional coordination polymers. The carboxylic groups of the ligands 1,2,3-btc³⁻, 1,3,5-Hbtc²⁻ and 1,2,4,5-btc⁴⁻ in the new Tl^I coordination polymers are not chelated and only act as bridging groups. In compounds 1-3, the lone pair of Tl(I) atoms is ‘active’ in the solid state and the coordination spheres are hemisphere type. Solution state luminescent spectra of compound 2 indicate intense fluorescent emissions at ca. 400 nm.